Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹7.31 Cr₹10 Cr--₹0.83 Cr

What is the latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS is ₹7.31 Cr based on Mar2025 Standalone results.
Year Capital Work in Progress
Mar2025₹7.31 Cr
Mar2024₹10 Cr
Mar2023-
Mar2022-
Mar2021₹0.83 Cr

How is Capital Work in Progress of BAFNA PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹7.31 Cr
-30.33
Mar2024 ₹10 Cr
0
Mar2023 -
0
Mar2022 -
-100.00
Mar2021 ₹0.83 Cr -

Compare Capital Work in Progress of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹284.6 Cr -6.2% -9.7% 52.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-6.2%

-9.7%

52.5%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses